Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03923270 |
|---|---|
| Brief Title: | Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer |
| First Submitted : | March 11, 2019 |
| First Submitted that Met QC Criteria : | April 18, 2019 |
| First Posted : | April 22, 2019 |
| Last Update Submitted that Met QC Criteria : | January 6, 2023 |
| Last Update Posted : | January 9, 2023 |